JANE STREET GROUP, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$8,884,000
+369.1%
257,855
+127.5%
0.01%
+400.0%
Q2 2020$1,894,000
+367.7%
113,365
+303.4%
0.00%
Q1 2020$405,000
-68.8%
28,100
-27.5%
0.00%
-100.0%
Q4 2019$1,299,000
+464.8%
38,783
+253.6%
0.00%
Q3 2019$230,000
-55.8%
10,967
-42.5%
0.00%
-100.0%
Q3 2018$520,000
+145.3%
19,072
+141.4%
0.00%
Q2 2018$212,000
-60.2%
7,900
-52.8%
0.00%
-100.0%
Q1 2018$533,000
+111.5%
16,741
+68.4%
0.00%
-50.0%
Q3 2015$252,0009,9430.00%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders